{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:28:16Z","timestamp":1790659696733,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10067-016-3301-2","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T13:50:09Z","timestamp":1463493009000},"page":"1789-1794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of IL1\u0392 (-511 A\/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis"],"prefix":"10.1007","volume":"35","author":[{"given":"N.","family":"Cubino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Montilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Usategui-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cieza-Borrela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Carranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Calero-Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Queiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Del Pino-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00edaz-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gonz\u00e1lez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"issue":"7318","key":"3301_CR1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang X-P, Tato CM, McGeachy MJ, Konkel JE et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling. Nature 467(7318):967\u201371","journal-title":"Nature"},{"issue":"3","key":"3301_CR2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-3083.1998.00399.x","volume":"48","author":"H Lettesj\u00f6","year":"1998","unstructured":"Lettesj\u00f6 H, Nordstr\u00f6m E, Str\u00f6m H, Nilsson B, Glinghammar B, Dahlstedt L et al (1998) Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 48(3):286\u201392","journal-title":"Scand J Immunol"},{"issue":"8","key":"3301_CR3","first-page":"1544","volume":"25","author":"C Ritchlin","year":"1998","unstructured":"Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25(8):1544\u201352","journal-title":"J Rheumatol"},{"issue":"1","key":"3301_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/keg443","volume":"43","author":"JS Ravindran","year":"2004","unstructured":"Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K et al (2004) Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 43(1):22\u20136","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3301_CR5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2004.031864","volume":"64","author":"L Peddle","year":"2005","unstructured":"Peddle L, Butt C, Snelgrove T, Rahman P (2005) Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis. Ann Rheum Dis 64(7):1093\u20134","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3301_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ard.2011.154690","volume":"71","author":"J Bowes","year":"2012","unstructured":"Bowes J, Ho P, Flynn E, Salah S, McHugh N, FitzGerald O et al (2012) Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility. Ann Rheum Dis 71(2):313\u20134","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3301_CR7","first-page":"168","volume":"14","author":"C Eklund","year":"2003","unstructured":"Eklund C, Jahan F, Pessi T, Lehtim\u00e4ki T, Hurme M (2003) Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw 14(3):168\u201371","journal-title":"Eur Cytokine Netw"},{"issue":"12","key":"3301_CR8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344(12):907\u201316","journal-title":"N Engl J Med"},{"issue":"1","key":"3301_CR9","first-page":"120","volume":"27","author":"G-M Alenius","year":"2009","unstructured":"Alenius G-M, Eriksson C, Rantap\u00e4\u00e4 DS (2009) Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol 27(1):120\u20133","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"3301_CR10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S et al (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369\u201376","journal-title":"J Clin Invest"},{"issue":"2","key":"3301_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2249.1992.tb02972.x","volume":"87","author":"NC Wood","year":"1992","unstructured":"Wood NC, Symons JA, Dickens E, Duff GW (1992) In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 87(2):183\u20139","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"3301_CR12","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar3396","volume":"13","author":"F Ceccarelli","year":"2011","unstructured":"Ceccarelli F, Perricone C, Fabris M, Alessandri C, Iagnocco A, Fabro C et al (2011) Transforming growth factor \u03b2 869C\/T and interleukin 6\u2013174G\/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther 13(4):R111","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3301_CR13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u201373","journal-title":"Arthritis Rheum"},{"issue":"6719","key":"3301_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JN Matthews","year":"1990","unstructured":"Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300(6719):230\u20135","journal-title":"BMJ"},{"issue":"8","key":"3301_CR15","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/art.22805","volume":"56","author":"D Heijde Van der","year":"2007","unstructured":"Van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C et al (2007) Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum 56(8):2698\u2013707","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3301_CR16","first-page":"67","volume":"25","author":"F Salaffi","year":"2007","unstructured":"Salaffi F, Carotti M, Garofalo G, Giuseppetti GM, Grassi W (2007) Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 25(1):67\u201374","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3301_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3899\/jrheum.111241","volume":"39","author":"O Fitzgerald","year":"2012","unstructured":"Fitzgerald O, Chandran V (2012) Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol 39(2):427\u201330","journal-title":"J Rheumatol"},{"issue":"12","key":"3301_CR18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/rheumatology\/ken374","volume":"47","author":"P Harrison","year":"2008","unstructured":"Harrison P, Pointon JJ, Chapman K, Roddam A, Wordsworth BP (2008) Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A\/G variant reveals association with rheumatoid arthritis. Rheumatology 47(12):1768\u201370","journal-title":"Rheumatology"},{"key":"3301_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-12-36","volume":"12","author":"M Emonts","year":"2011","unstructured":"Emonts M, Hazes MJMW, Houwing-Duistermaat JJ, van der Gaast-de Jongh CE, de Vogel L, Han HKH et al (2011) Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet 12:36","journal-title":"BMC Med Genet."},{"issue":"10","key":"3301_CR20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-010-1504-5","volume":"29","author":"N Jung","year":"2010","unstructured":"Jung N, Hellmann M, Hoheisel R, Lehmann C, Haase I, Perniok A et al (2010) An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin Rheumatol 29(10):1169\u201373","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3301_CR21","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","volume":"63","author":"SB Cohen","year":"2004","unstructured":"Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ et al (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63(9):1062\u20138","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3301_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03009740510026373","volume":"34","author":"A Pawlik","year":"2005","unstructured":"Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34(2):109\u201313","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"3301_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2005.037465","volume":"65","author":"RJ Fran\u00e7ois","year":"2006","unstructured":"Fran\u00e7ois RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 65(6):713\u201320","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3301_CR24","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1002\/art.21308","volume":"52","author":"F Paladini","year":"2005","unstructured":"Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A et al (2005) Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondyloarthropathies. Arthritis Rheum 52(10):3319\u201321","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3301_CR25","first-page":"2511","volume":"30","author":"N Dalbeth","year":"2003","unstructured":"Dalbeth N, Dockerty JL, Williamson L (2003) Influence of HLA-B27 on the clinical presentation of psoriatic arthritis. J Rheumatol 30(11):2511, author reply 2511\u20132","journal-title":"J Rheumatol"},{"issue":"4","key":"3301_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/03009742.2013.863381","volume":"43","author":"SS Johnsen","year":"2014","unstructured":"Johnsen SS, Bakland G, Nossent JC (2014) The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway. Scand J Rheumatol 43(4):296\u2013300","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3301-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3301-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:59:32Z","timestamp":1559120372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3301-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3301"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3301-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}